Frontera Health
Category: AI in Healthcare
AI-powered digital phenotyping solution designed to enhance autism care by transforming therapeutic session videos into data-driven clinical insights. Frontera Health was founded in 2023. The company is led by Amol Deshpande. Based in Denver, Colorado. Team size: 200. Total funding raised: $32M. Latest round: Seed round. Key investors include Lux Capital, Lightspeed Venture Partners, Bison Ventures, Menlo Ventures, Inspired Capital.
- Founded
- 2023
- Headquarters
- Denver, Colorado
- Team size
- 200
- Total funding
- $32M
Value proposition
Provides precise, data-driven insights from therapeutic sessions to accelerate diagnosis and reduce administrative burdens for clinicians
Products and solutions
Digital Phenotyping Solution, Diagnosis Builder, Assessment Builder
Unique value
Transforms video recordings of therapy sessions into detailed clinical data at 30 frames per second
Target customer
Clinicians (particularly Board-Certified Behavior Analysts) and families with children requiring autism care
Industries served
Healthcare, Autism Care, Applied Behavior Analysis (ABA)
Technology advantage
Leverages advanced AI to deliver real-time, objective insights that enable faster, more accurate diagnoses while reducing clinician workload
How they differentiate
Focuses on AI-driven digital phenotyping for real-time analysis and data extraction at an unprecedented frame rate, specifically targeting underserved communities
Main competitors
SpectrumAi, Acclaim Autism
Key partnerships
Collaborations with Board-Certified Behavior Analysts (BCBAs) and clinical experts
Major milestones
Company launch scheduled for early 2025 Relocation to a new LoDo office in Denver Launch of the multi-modal digital phenotyping solution
Growth metrics
Approximately 200 employees; detailed revenue metrics not publicly disclosed
Market positioning
Positions itself as a leader in AI-enabled autism care with innovative diagnostic and assessment solutions
Geographic focus
Primarily focused on the United States, with an emphasis on underserved and rural areas
Patents and IP
Patent pending for its digital phenotyping technology
About Amol Deshpande
Amol Deshpande is a seasoned entrepreneur and executive with a strong background in both technology and venture capital. He co-founded and served as the CEO of Farmer's Business Network (FBN), a prominent ag-tech company, for nearly a decade, leading it to a multi-billion dollar valuation. Prior to his entrepreneurial ventures, he was a partner at the prestigious venture capital firm Kleiner Perkins. His personal experience as a parent of a child with autism motivated him to establish Frontera Health, where he now serves as Founder and CEO, aiming to revolutionize autism care through AI. He also runs his own VC fund, Divergent Investments.
Official website: https://www.fronterahealth.com